p14ARF interacts with the SUMO-conjugating enzyme Ubc9 and promotes the sumoylation of its binding partners

Helen Rizos1, Sarah Woodruff, Richard F Kefford

  • 1Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, Australia. helen_rizos@wmi.usyd.edu.au

Insights

The tumor suppressor p14ARF promotes cell cycle arrest by enhancing SUMO-1 modification of binding partners like hdm2 and E2F-1. Melanoma-associated p14ARF mutations disrupt this crucial sumoylation process.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • p14ARF is a tumor suppressor regulating cell cycle arrest in response to abnormal growth.
  • Alterations in p14ARF are frequent in human cancers and linked to melanoma susceptibility.
  • The precise mechanism of p14ARF action requires further elucidation.

Purpose of the Study:

  • To investigate the role of SUMO-1 modification in p14ARF tumor suppressor function.
  • To identify p14ARF binding partners that undergo SUMO-1 modification.
  • To determine if cancer-associated p14ARF mutations affect this modification process.

Main Methods:

  • Co-immunoprecipitation assays to detect protein interactions.
  • Western blotting to assess SUMO-1 conjugation (sumoylation).
  • Analysis of p14ARF interaction with Ubc9 and its effect on target protein sumoylation.

Main Results:

  • p14ARF interacts with the SUMO E2 conjugating enzyme, Ubc9.
  • p14ARF enhances the sumoylation of its binding partners: hdm2, E2F-1, HIF-1alpha, TBP-1, and p120E4F.
  • Melanoma-associated p14ARF mutations impair p14ARF-induced sumoylation.

Conclusions:

  • p14ARF utilizes SUMO-1 modification of diverse binding partners as a mechanism for tumor suppression.
  • Disruption of p14ARF-mediated sumoylation by specific mutations may contribute to melanoma development.
  • This study reveals a novel pathway for p14ARF action involving post-translational modification.

Related Concept Videos

Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
Protein Complexes with Interchangeable Parts01:57

Protein Complexes with Interchangeable Parts

Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order to...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...